Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination
IntroductionIn addition to its direct cytotoxic effects, ablative therapies as electrochemotherapy (ECT) can elicit indirect antitumor effects by triggering immune system responses. Here, we comprehensively analyzed this dual effectiveness of intratumoral ECT with chemotherapeutic drugs bleomycin (B...
Saved in:
Main Authors: | Katja Uršič Valentinuzzi, Urška Kamenšek, Simona Kranjc Brezar, Chloe Heranney, Tilen Komel, Simon Buček, Maja Čemažar, Gregor Serša |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1470432/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor microbiome: roles in tumor initiation, progression, and therapy
by: Shengxin Zhang, et al.
Published: (2025-02-01) -
A polysaccharide-based hydrogel platform for tumor spheroid production and anticancer drug screening
by: Elliot Lopez-Vince, et al.
Published: (2025-02-01) -
Gastrointestinal stromal tumors
by: A. P. Seryakov
Published: (2010-08-01) -
Surgical planning of small intestine neuroendocrine tumors: the concept of mesenteric tumor deposits
by: Romain L’Huillier, et al.
Published: (2025-02-01) -
The Effect of Tumor Angiogenesis Agents on Tumor Growth Dynamics: A Mathematical Model
by: Ali Mohseni, et al.
Published: (2025-01-01)